Welcome to LookChem.com Sign In|Join Free

CAS

  • or
C11H16N2O2S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1093071-69-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1093071-69-2 Structure
  • Basic information

    1. Product Name: C11H16N2O2S
    2. Synonyms: C11H16N2O2S
    3. CAS NO:1093071-69-2
    4. Molecular Formula:
    5. Molecular Weight: 240.326
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1093071-69-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C11H16N2O2S(CAS DataBase Reference)
    10. NIST Chemistry Reference: C11H16N2O2S(1093071-69-2)
    11. EPA Substance Registry System: C11H16N2O2S(1093071-69-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1093071-69-2(Hazardous Substances Data)

1093071-69-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1093071-69-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,3,0,7 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1093071-69:
(9*1)+(8*0)+(7*9)+(6*3)+(5*0)+(4*7)+(3*1)+(2*6)+(1*9)=142
142 % 10 = 2
So 1093071-69-2 is a valid CAS Registry Number.

1093071-69-2Relevant articles and documents

KINASE INHIBITOR COMPOUNDS

-

Page/Page column 29, (2009/01/24)

Pyrimidinone derivatives have enhanced and unexpected drug properties as inhibitors of protein kinases and are useful in treating disorders related to abnormal protein kinase activities such as inflammatory diseases and certain types of cancer.

SUBSTITUTED PYRIMIDINONES

-

Page 251, (2008/06/13)

Disclosed are compounds Formula I and pharmaceutically acceptable salts thereof, wherein R1, R2, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1093071-69-2